Previous Article | Next Article ![]()
Journal of Clinical Microbiology, August 2007, p. 2392-2397, Vol. 45, No. 8
0095-1137/07/$08.00+0 doi:10.1128/JCM.00556-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Institute for Medical Microbiology and Epidemiology of Infectious Diseases, University of Leipzig, Leipzig, Germany,1 Department of Microbial Pathogenesis, Helmholtz Center for Infection Research, GBF German Research Centre for Biotechnology, Braunschweig, Germany,2 Institute for Biochemistry, School of Medicine, University of Leipzig, Leipzig, Germany3
Received 13 March 2007/ Returned for modification 20 April 2007/ Accepted 29 May 2007
|
|
|---|
|
|
|---|
Viridans streptococci (VS) are commensal bacteria of the human oral cavity and the respiratory, gastrointestinal, and genitourinary tracts. On the other hand, they are responsible for several systemic diseases, including subacute infective endocarditis, septicemia, meningitis, and pyogenic infections (1, 9, 17). The heterogeneous group of VS currently includes more than 30 species. They form five major groups, namely, the mutans, salivarius, anginosus, mitis, and bovis groups (16). The accurate species-level identification of isolates from relevant clinical specimens, like blood and abscess material, is important in understanding the pathogenic mechanisms of the particular species. Unfortunately, species identification seems to be more difficult for VS than for other groups of bacteria, possibly because VS are competent bacteria and, thus, may readily take up DNA from the environment.
Phenotypic test systems do not always allow the accurate identification of some species in this heterogeneous group of bacteria (3, 10). Several molecular methods for the identification of VS to the species level have been developed. The targets of the molecular methods are, e.g., the 16S RNA gene, the 16S-23S rRNA gene intergenic spacer region (7), the D-alanine-D-alanine ligase gene (11), hyaluronate lyase genes (27), and the glucosyltransferase gene (14). Species of the mitis group are especially difficult to differentiate by these methods (C. Friedrichs et al., submitted for publication). This may be because the nucleotide sequences of the 16S rRNA genes of Streptococcus mitis, S. oralis, S. pseudopneumoniae, and S. pneumoniae match by more than 99% (16).
Several gram-negative bacteria, gram-positive bacteria, and Mycobacterium species have been analyzed by MALDI-TOF-MS (8, 21, 29). Beta-hemolytic streptococci could be arranged into group A, C, and G streptococci by MALDI-TOF-MS analysis (18).
The differentiation of oral streptococci at the species level and the mutans streptococci at the subspecies level was achieved by MALDI-TOF-MS (25). The aim of the present study was to evaluate the use of MALDI-TOF-MS for the rapid identification of 10 different species of VS isolated from relevant clinical samples.
|
|
|---|
-cyano-4-hydroxycinnamic acid were purchased from Bruker Daltonics, Bremen, Germany; trifluoroacetic acid (TFA) was from Merck, Darmstadt, Germany; and acetonitrile was from Sigma, Taufkirchen, Germany. Deionized water was used in all experiments. Columbia agar base and the other media used were purchased from Oxoid, Basingstoke, United Kingdom. Bacterial strains, culture, and phenotypic biochemical and genotypic identification. A total of 99 consecutive clinical isolates of VS were recovered from blood cultures (n = 25), aspirates of peritonsillar abscesses (n = 21), several other abscesses (n = 18), wound swabs (n = 29), catheter tips (n = 5), and cerebrospinal fluid (n = 1). All isolates were subcultured at 37°C in 5% CO2 on 5% sheep blood agar and chocolate agar. The strains were all preliminarily identified as VS on the basis of alpha-hemolysis, colony characteristics, a positive Gram stain reaction, coccus morphology in chains, and a negative catalase test result. Pneumococci and enterococci were eliminated by routine biochemical assays, like the optochin test and bile solubility, pyrrolidonylarylamidase, and oxacillin testing. The isolates were biochemically identified with the Rapid ID 32 STREP system (bioMérieux, Lyon, France); and genotypic identifications were performed by previously described species-specific PCRs for S. oralis (14); S. gordonii, S. mitis, S. mutans, S. salivarius, and S. sanguinis (11); S. anginosus, S. constellatus, and S. intermedius (27); and S. parasanguinis (Friedrichs et al., submitted) or, in some cases, by sequence analysis of the 16S rRNA gene (5, 7).
Standard samples. The following reference strains were used in this study for MALDI-TOF-MS analyses: S. intermedius DSM 20573, S. mutans DSM 20523, S. oralis DSM 20627, S. parasanguinis DSM 6778, S. salivarius DSM 20560, S. sanguinis DSM 20567, S. mitis DSM 12643, S. constellatus subsp. constellatus DSM 20575, S. anginosus DSM 20563, and S. gordonii DSM 6777 (DSMZ, Braunschweig, Germany). In addition to these strains, we selected from our in-house culture collection two additional strains of each species on the basis of a coherent previous identification by phenotypic and genotypic methods.
Sample preparation for MALDI-TOF-MS.
Individual colonies of the respective bacterial species were recultured in brain heart infusion overnight. One milliliter of bacterial suspension was centrifuged at 7,500 x g for 15 min. The sediment was washed twice with deionized water and then dissolved in 50 µl 80% TFA. After 10 min incubation at room temperature 150 µl deionized water and 200 µl acetonitrile were added. The samples were stored at –20°C. After the samples were thawed, they were centrifuged at 13,000 rpm for 2 min. The supernatant was transferred into a 1.5-ml Eppendorf tube and dried in a vacuum centrifuge. The pellet was dissolved in 20 µl 2.5% TFA-50% acetonitrile. One microliter was pipetted onto the stainless steel MALDI target plate. After the spots dried, they were overlaid with 1.0 µl of matrix (
-cyano-4-hydroxycinnamic acid as a saturated solution in 2.5% TFA-50% acetonitrile). The matrix/sample spots were crystallized by air drying.
MALDI-TOF-MS parameters. All mass spectra were acquired with an Autoflex (Bruker Daltonics, Bremen, Germany) MALDI-TOF mass spectrometer with a nitrogen laser (337 nm) operated in the positive linear mode (delay, 150 ns; voltage, 20 kV; mass range, 2 to 50 kDa) under the control of Flexcontrol software (version 2.4; Bruker Daltonics). Each spectrum was obtained by averaging 500 laser shots acquired in the automatic mode at the minimum laser power necessary for ionization of the samples. The spectra were externally calibrated by using the standard calibration mixture, Protein Calibration Standard I, supplied by Bruker Daltonics. The data files were transferred to the Flexanalysis software (version 2.4; Bruker Daltonics) for automated peak extraction.
MALDI-TOF-MS statistical analysis. With the Flexanalysis software, 40 peaks were automatically labeled in each spectrum according to their appearance above the background (threshold ratio, 1.5). Correct labeling was controlled manually. Peak lists containing masses and intensities were exported as ASCII files. Similarity analysis between peak lists was carried out by using a hierarchical clustering procedure performed with MatLab software (version 7.3; The MathWorks Inc., Natick, MA). To identify the corresponding peaks in the different spectra, a mass window was defined around each peak. The mass window considers the differences of masses assigned to identical peaks in different samples. A mass-dependent size of the mass window was chosen according to the following equation: mass window size = sizeabs + (mass·sizerel), where sizeabs is the absolute mass-dependent size and sizerel is the relative mass-dependent size.
Typically, a sizeabs of 1 Da and a sizerel of 1.001 were applied. Peaks originating from different spectra and occurring in the same window were assigned to one "cluster." If neighboring clusters overlapped, they were omitted from further calculations. The similarity between spectra was determined by pairwise comparison of the spectra by counting the number of clusters to which the two spectra contributed. By this procedure, a symmetric matrix of pairwise similarities (peak mass-based similarity matrix) was formed. In addition, a similarity matrix (
i,j), which considers peak masses and differences in the peak intensities, was calculated according to the following equation:
![]() |
represents the intensity of peak i in spectrum k.
Distance matrices (
i,j) were calculated from normalized similarity matrices according to the following equation:
![]() |
For classification of the spectra, the support vector machine (SVM) tool implemented in the Bioinformatic toolbox of MatLab (version 7.3; The MathWorks Inc.) was used. This software, which features an efficient two-class classification, enables the user to define a number of parameters and to select from a choice of built-in kernel functions, including a radial basis function and a polynomial kernel (of a given degree). The SVM algorithm (31) was trained with a set of spectra of bacteria of known identity. An error estimate of the class prediction was carried out by calculation of a 10-fold cross-validation error for the training group. For this purpose, the training set was first divided into 10 subsets of equal size. Sequentially, one subset was tested by using the classifier trained on the remaining nine subsets. Thus, each probe of the training set was predicted once. The cross-validation accuracy is the percentage of data which were correctly classified.
|
|
|---|
![]() View larger version (19K): [in a new window] |
FIG. 1. MALDI-TOF mass spectra of different streptococcal reference strains: S. oralis DSM 20627, S. mitis DSM 12643, S. gordonii DSM 6777, S. sanguinis DSM 20567, S. parasanguinis DSM 6778, S. anginosus DSM 20563, S. constellatus DSM 20575, S. intermedius DSM 20573, S. salivarius DSM 20560, and S. mutans DSM 20523.
|
![]() View larger version (6K): [in a new window] |
FIG. 2. Results of similarity analysis of reference strains and additional reference strains. The dendrogram was calculated from a peak mass-based similarity matrix. G1 and G2, S. gordonii DSM 6777, respectively; G3 and G4, two different culture collection strains of S. gordonii, respectively; P1 and P2, two colonies of S. parasanguinis DSM 6778, respectively; P3 and P4, two different culture collection strains of S. parasanguinis, respectively; I1 and I2, two colonies of S. intermedius DSM 20573, respectively; I3 and I4, two different culture collection strains of S. intermedius, respectively; C1 and C2, two colonies of S. constellatus DSM 20575, respectively; C3 and C4, two different culture collection strains of S. constellatus, respectively; A1 and A2, two colonies of S. anginosus DSM 20563, respectively; A3 and A4, two different culture collection strains of S. anginosus, respectively; San1 and San2, two colonies of S. sanguinis DSM 20567, respectively; San3 and San4, two different culture collection strains of S. sanguinis, respectively; Mi1 and Mi2, two colonies of S. mitis DSM 12643, respectively; Mi3 and Mi4, two different culture collection strains of S. mitis, respectively; O1 and O2, two colonies of S. oralis DSM 20627, respectively; O3 and O4, two different culture collection strains of S. oralis, respectively; Sal1 and Sal2, two colonies of S. salivarius DSM 20560, respectively; Sal3 and Sal4, two different culture collection strains of S. salivarius, respectively; Mu1 and Mu2, two colonies of S. mutans DSM 20523, respectively; Mu3 and Mu4, two different culture collection strains of S. mutans, respectively.
|
![]() View larger version (15K): [in a new window] |
FIG. 3. Results of the identification of one clinical sample (isolate VS 162) on the basis of a similarity analysis of the MALDI-TOF mass spectra. The peak list generated from the spectrum of VS 162 was compared to the peak lists of all reference and culture collection strains (VS database). On the y axis, the distance between the spectrum of VS 162 and the spectra of the references and culture collection (all measured in triplicate) is given. On the x axis, the entries of the VS database are arranged according to the increasing dissimilarities of their MALDI-TOF-MS spectra compared to the spectrum of VS 162. For clarity, only the results for the 19 most similar entries of the VS database are shown. San1-1, San1-2, and San1-3, triplicate cultures of S. sanguinis DSM 20567; San2-1, San2-2, San3-1, San3-2, San4-1, and San4-2, duplicate cultures of three different culture collection strains of S. sanguinis; G1-2 and G1-3, duplicate cultures of S. gordonii DSM 6777 Il-2, S. intermedius DSM 20573; C2-1, C2-2, and C3-1, duplicate cultures and single culture of two different culture collection strains of S. constellatus; A1-1, culture collection strain of S. anginosus; O3-2, culture collection strain of S. oralis. Identical entries at different positions on the x axis represent duplicate MALDI-TOF mass spectra from one culture.
|
|
View this table: [in a new window] |
TABLE 1. Identification of 99 VS strains by MALDI-TOF MS and reference methods
|
![]() View larger version (33K): [in a new window] |
FIG. 4. Examples of results of the identification of the 23 samples which could be identified as either S. mitis or S. oralis by species-specific PCR and sequence analysis of the 16S RNA gene (Table 1, S. oralis/S. mitis [one clinical sample]) on the basis of a similarity analysis of the MALDI-TOF mass spectra. The peak list generated from the spectra were compared to the peak lists of all reference and culture collection strains (VS database). On the y axis, the distance between the spectrum of the respective clinical isolate and the spectra of the reference and culture collection isolates (all measured in triplicate) is given. On the x axis, the entries of the VS database are arranged according to the increasing dissimilarities of their MALDI-TOF-MS spectrum compared to the spectrum of the respective clinical isolate. (a) Results of identification of a clinical sample which can be identified as S. oralis; (b) results of identification of a clinical sample which can be identified as S. mitis; (c) results of identification of a clinical sample (VS 23) which cannot be identified as either S. oralis or S. mitis. See the legends to Fig. 2 and 3 for an explanation of the VS database designations.
|
In conclusion, our findings indicate that MALDI-TOF-MS, in combination with pattern analysis, may be useful for the rapid and accurate identification of VS. Currently, however, the high investments necessary for this methodology might preclude routine microbiological laboratories from using this technology. Established genotyping methods based on the 16S rRNA gene do not allow the correct differentiation of S. oralis and S. mitis because the intraspecies sequence variations may be higher than the interspecies variations (7, 23, 28). In contrast, phenotypic classification with the SVN algorithm based on MALDI-TOF mass spectra allowed the accurate differentiation between S. oralis and S. mitis. Discrimination between S. oralis and S. mitis is of clinical relevance, since some studies have shown that S. mitis strains are more resistant to penicillin, fluoroquinolones, and three or more classes of antibiotics (13, 24).
The work was supported by an award of the Virtual Institute from the Impuls- und Vernetzungsfond of the Helmholtz Association.
Published ahead of print on 6 June 2007. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2010 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»